Cleared Special

K140937 - OSSEOFLEX SB

K140937 is an FDA 510(k) clearance for OSSEOFLEX SB, manufactured by Osseon, LLC. The device is a Class 2 Orthopedic device with product code NDN cleared through the Special 510(k) pathway after a 69-day FDA review.

K140937 · Osseon, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2014
Decision
69d
Days
Class 2
Risk

K140937 is an FDA 510(k) clearance for the OSSEOFLEX SB. Classified as Cement, Bone, Vertebroplasty (product code NDN), Class II - Special Controls.

Submitted by Osseon, LLC (Santa Rosa, US). The FDA issued a Cleared decision on June 19, 2014 after a review of 69 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3027 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Osseon, LLC devices

FDA 510(k) Submission Details - K140937

510(k) Number K140937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 11, 2014
Decision Date June 19, 2014
Days to Decision 69 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 122d · This submission: 69d
Pathway characteristics
Modification to existing cleared device.

NDN Device Classification - Class 2, Special Controls

Product Code NDN Cement, Bone, Vertebroplasty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3027
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - NDN Cement, Bone, Vertebroplasty

All 53
Devices cleared under the same product code (NDN) and FDA review panel - the closest regulatory comparables to K140937.
Kyphon HV-R Bone Cement
K160983 · Medtronic, Inc. · Aug 2016
KYPHON XPEDE Bone Cement
K151227 · Medtronic · Nov 2015
Vertaplex® High Viscosity (HV) Radiopaque Bone Cement
K150582 · Stryker Corporation · Jun 2015
STRYKER IVAS BALLOON CATHETER
K123942 · Stryker Corporation · Apr 2013
IVAS BALLOON CATHETER
K113154 · Stryker Corporation · Jan 2012
CONFIDENCE HIGH VISCOSITY SPINAL CEMENT, 16G / 20G
K112907 · Medos International SARL · Dec 2011